ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Jylamvo 2 mg/ml, Lösung zum Einnehmen - 
68411001 Ideogen AG
Jylamvo 2 mg/ml, Lösung zum Einnehmen08.08.2022
  08.08.2022
Methotrexate (L04AX03) 
WHO-DDD07.08.2027
07.10.60. 
07.16.10. 
A  
Yes 
IPCI
109.73Yes
    
10 %135.75
7680684110016Synthetika
  
Composition
methotrexatum 2 mg, macrogolum 400, E 214 0.2 mg, E 219 2 mg, glycerolum, aromatica (Orange) cum sorbitolum et E 220, sucralosum, trinatrii citras dihydricus ad pH, acidum citricum ad pH, aqua purificata, q.s. ad solutionem pro 1 ml corresp. natrium 3.35 mg.
Packungsbestandteile
Solution (oral) 
  
 
Active AgentDose
Methotrexate2 mg/ml
BAG: Active AgentDose
Methotrexate2 mg
 
Inactive agentsDoseadditional_information
Acidum Citricum ad Ph  
Aqua Purificata  
Aromatica (Orange) cum Sorbitolum  
E 2140.2 mg/mlconserv.
E 2192 mg/mlconserv.
E 220 conserv.
Glycerol  
Macrogol400  
Sucralosum  
Trinatrii Citras Dihydricus ad Ph  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home